Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32438 total
SMMT enters the second half of August with an unusual alignment — shorts are covering, options traders are increasingly bullish, and insiders are buying with conviction, all while the Street remains deeply divided on…
Palantir Technologies has extended its post-earnings surge to nearly 38% over the past month, closing Tuesday at $174.94, and the gap between where the stock trades and where most analysts have it pegged remains the…
Immunome walks into its August 13 earnings report with two analyst target raises landing on the same morning — a signal that at least part of the Street is growing more constructive even as insiders continue to sell…
Hyliion Holdings reported Q2 results on August 12 with short sellers at their most aggressive positioning in months — and the post-earnings picture shows the bears aren't backing down. Short interest is the headline.…
SNOW heads into its August 26 earnings date with shorts unwinding, analysts chasing the stock higher, and options traders turning the most defensive they've been in a year — a setup where the bullish price action and…
Rocket Companies enters the post-earnings period with a story that has shifted sharply in four days: short sellers who refused to budge after two disappointing prints are now covering at a rate not seen in months,…
Cogent Biosciences printed its Q2 results on August 13 into a stock already down nearly 10% on the week — and the data since has shifted meaningfully from the bullish setup described in notes filed earlier this…
DoubleDown Interactive enters the back half of 2026 with fresh analyst conviction behind it, a stock that has climbed 8% over the past month, and a short interest profile so thin it barely registers as a pressure…
NetEase heads into its August 20 earnings release with a more charged short-side build than the price action alone suggests. The most striking feature of the past six weeks is how aggressively shorts have accumulated.…
COMPASS Pathways enters the second half of August with a striking disconnect — the stock is up 13% on the week and has nearly doubled year-to-date, yet short sellers have been rebuilding positions at a pace not seen in…
STLAM has fallen nearly 5% this week to €4.75, underperforming most of its European automotive peers — and the gap between where the stock trades and where the lending market thinks it deserves to go is widening in a…
Legend Biotech enters the post-earnings period with short sellers accelerating and the Street sharply divided — a collision that makes this week's setup unusually charged. Short interest has become the dominant story.…
Chord Energy just posted its August results and rallied through them, yet short sellers responded by rebuilding positions at the fastest weekly pace in months — a split signal worth watching closely. The short-interest…
Definium Therapeutics enters the back half of August with a curious split: the Street is racing to lift price targets after positive Phase III data, yet the stock has shed 13% over the past month and shorts remain dug…
Progyny enters the back half of August in a fundamentally different position than it occupied a week ago — a bruising post-earnings selloff has wiped out months of gains and forced a rapid reassessment across the…
KRT is trading at a deep discount to its own momentum: the stock has jumped 22% in a week and 46% in a month, while the only analyst with a live target is still pointing to $34 — well below Tuesday's close of…
10x Genomics enters the post-earnings week with an unusual tension: short sellers are quietly rebuilding positions into a stock that just rocketed 22% in a single week, while analysts race to lift targets that the…
BX has spent the past week unwinding a textbook crowding-unwind trade — the stock up 7.3%, shorts pulling back sharply, and a freshly post-earnings Street scrambling to catch up on targets — all while the borrow market…
BORR enters the week with an unusual split — the stock gained 6% while the borrow market tightened to levels that suggest bears are pressing harder, not retreating. Short interest has climbed to 10.5% of the free…
BridgeBio Pharma has flipped its positioning story in 48 hours — shorts are covering at pace, analysts are lifting targets in unison, and the options tape has swung from extreme bullishness to a defensive pulse that…
